The National Treasury has set aside Kshs.7 billion to acquire the second batch of Covid-19 vaccines. The money has been allocated in the 2nd supplementary budget for Financial Year 2020/2021 to be tabled before the National Assembly.
The vaccines will cater for the month of May and June and will be acquired through the Covax Facility. National Treasury CS Ukur Yatani stated that the Kenya Medical Supplies Authority (KEMSA) will not be engaged in acquisition of the vaccines and its distribution. Instead, the money will be sent directly to the suppliers and manufacturers of the vaccines. Covax Facility aims at ensuring equitable distribution of 2Billion Covid 19 vaccines to populations in lower income economies.
Over 750,000 Kenyans have been vaccinated so far, and the government is set to expand the vaccines beyond the original target of high priority groups, such as frontline healthcare workers followed by people above 58years, who were the first to be vaccinated.
The government is pursuing acquisition of one (1) million doses of vaccine each from Pfizer as well as Johnson & Johnson to supplement the AstraZeneca Vaccine currently being distributed in Kenya.